T1	Participants 24 69	allogeneic sibling stem-cell transplantation:
T2	Participants 111 124	French study.
T3	Participants 325 390	prospective French study comparing four doses of immunoglobulins.
T4	Participants 407 452	hematopoietic stem-cell transplant recipients
T5	Participants 535 604	85 patients from five centers were collected prospectively and costed
T6	Participants 760 828	patient's pretransplant status and transplant-related complications.
T7	Participants 1442 1472	homogeneous group of patients.
